Login Form

Please log in to gain access to the full suite of EUROCORD-ED educational resources for members.


Webcasts

Note: to view these webcasts you need to be a registered user

World Cord Blood Congress III, Roma, Italy, October 2011

ESH - EBMT Training Course Blood and Marrow Transplantation, La Baule, France, May 2011

ESTM Cord Blood Banking Conference, Pescara, Italy, November 2009

ESH-EBMT Training Course, Latimer, UK, May 2009

ESH-Eurocord-Netcord Cord Blood Conference, Mandelieu, France, October 2008


Social media


Follow us on

Subscribe to news alert

Enter your email address:

Delivered by FeedBurner

This website is certified by Health  On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:
verify here.

EUROCORD-ED is the European Online Cord Blood Learning Portal for use by Doctors, Nurses, Midwives, Surgeons, UCB Processing & Testing Laboratories, Scientists and Study Groups.

Eurocord-Ed Eurocord-Ed

Archived News

51 articles available. Page : 1 2 3 4 5 6

AusCord Survey on handling UCB units prior to transplant
published 2012-01-10 11:01:44 by Nancy Hamilton

The AusCord cord blood banks, comprising BMDI Cord Blood Bank, Queensland Cord Blood Bank and Sydney Cord Blood Bank, are conducting an evaluation of their processes with the view to harmonise their operations.  We are interested in gathering feedback from transplant centres regarding their procedures for handling the cord blood units prior to transplantation.  
We would be very grateful if you could please complete the 5-question questionnaire to be found at http://www.surveymonkey.com/s/PPTRCCV before January 31st, 2012.  Thanks for your input and we look forward to your response.


ESH Updates in Clinical Hematology
published 2012-01-09 09:01:55 by Nancy Hamilton

Professor Eliane Gluckman is one of the co-chairs of the upcoming ESH Updates in Clinical Hematology conference to be held in Paris on February 9-10, 2012 in Paris.

This conference is part of a new series features: a 1,5 day update on patient management from world class experts, a clinically and practically oriented program that reflects most recent state-of-the-art as well as innovation, in a mixture of different hematologic disorders, – in-depth presentations followed by interactive discussions, including clinical cases and controversies, and a handout comprising lecture summaries, slides and recent, selected references.

Professor Gluckman will chair the openning session on Stem Cell Transplant.  For more information and to register please follow this link.



Eurocord-Ed Policy Document on Cord Blood Banking in Europe
published 2011-12-20 05:12:15 by Nancy Hamilton

Since the first cord blood transplantation was performed in Europe in 1988, a large number of cord blood banks have been established in order to facilitate unrelated cord blood transplantation. Over the years the number of units collected in Europe has increased to approximately 190 000 in 2011. Cord blood transplantation is a rapidly growing field with an increasing number of indications worldwide. The results reported by Eurocord reflect a strikingly rapid increase in activity. For example, the Asian Pacific Blood and Marrow Transplantation Group reported 937 cord blood transplants in 2008 alone. In the USA, more than 40% of paediatric unrelated transplants are provided by cord blood.
Read more : Click here

Congrès International sur le sang de cordon ombilical présidé par E. Gluckman à  Marseille du 4 au 7 novembre 2010
published 2011-12-16 11:12:31 by Nancy Hamilton

Ces 4 journées ont réuni des scientifiques, des cliniciens et des responsables de banques de sang de cordon de tous les pays, pour confronter leurs projets, leurs études et leurs résultats.  Pour plus d'informaton:

PDF

Congrès International sur le sang de cordon ombilical présidé par E. Gluckman à Marseille du 4 au 7 novembre 2010
published 2011-12-16 11:12:23 by Nancy Hamilton

Ces 4 journées ont réuni des scientifiques, des cliniciens et des responsables de banques de sang de cordon de tous les pays, pour confronter leurs projets, leurs études et leurs résultats See .pdf for full article.
PDF

2nd Eurocord-Ed forum on LinkedIn
published 2011-12-07 09:12:34 by Nancy Hamilton

PROFESSOR ELIANE GLUCKMAN IS AVAILABLE TO ANSWER YOUR QUESTIONS ON CORD BLOOD TRANSPLANTATION

ESH  and Eurocord-Ed are very pleased to announce that Professor Eliane Gluckman will be available to respond to questions via the Eurocord-Ed linkedIn group on Thursday, December 15, 2011 from 14:30 to 15:30 Central European Time (CET). The direct link is http://www.linkedin.com/myGroups?trk=hb_side_mygrps

Hanoi workshop november 10-11, 2011.News from the international workshop on bringing hematopoietic transplantation in emerging countries
published 2011-12-02 10:12:53 by gluckman eliane

Haematopoietic stem cell transplantation has advanced to the level of being the only curative treatment for many haematological and non-haematological diseases. The frequency of stem cell transplantation varies considerably among the world regions and is dependent upon the national income and the resources devoted to health expenditures.
The primary mission of the Worldwide Network for Blood & Marrow Transplantation (WBMT, www.wbmt.org), a federation of eighteen (18) international societies involved in stem cell transplantation around the world, is to establish broad standards andassist countries with limited resources in development and performance of this curative treatment. To this end, WBMT, in association with the World Health Organization (WHO),is planning a meeting in Vietnam with the participation of health authorities from at least sixteen (16) countries with restricted resources and low transplant frequency (Gratwohl JAMA 2010). It is our goal not only to guide physicians to optimize their current stem cell transplantation activities but also to create awareness among policy makers aboutthe value of stem cell transplantation so that these activities might be expanded. Representatives from established transplant centers in countries with limited resources will also participate, with the goal of optimizing their own programs and guiding countries without experience to establish effective and resource sparing programs.

PDF / Direct link

Highlights from the 2011 World Cord Blood Congress
published 2011-12-01 06:12:44 by Nancy Hamilton

The ESH, Eurocord, Eurocord-Ed EBMT World Cord Blood Congress held in Rome, Italy from October 27-29, 2011 was a tremendous success thanks to the beautiful surroundings offered by the historic site in the city centre, the quality of the scientific programme, and the lively interaction with attendees. 
The congress took place in the centre of Rome on the Piazza Montecitorio adjacent to the Italian parliament building. Over 320 participants from fifty-two countries and from as far away as Canada, Argentina China and Australia attended the event.
The 2011 meeting focussed on Cord Blood Transplant, immunological aspects, and clinical results. All sessions were divided into three key sections: the current State-of-the-art, expert short communications, and  panel discussions.
According to attendee feedback, the possibility to discuss openly with internationally renowned specialists in both scientific and social settings was particularly appreciated   The local organizers: William Arcese, Franco Locatelli, and Paolo Rebulla all deserve special thanks as do the Staff of the European School of Haematology. Eliane Gluckman

Cord Blood: Biology, Transplantation, Banking, and Regulation
published 2011-11-30 08:11:56 by Nancy Hamilton

Cord Blood: Biology, Transplantation, Banking, and Regulation

Education and CME

The Eurocord-Ed Consortium highly recommends the recently pulblished 2011 version of  Cord Blood: Biology, Transplantation, Banking, and Regulation Edited by Hal E. Broxmeyer of the Indiana University School of Medicine and published by AABB Press. Contents include Cord Blood Biology: Hematopoiesis, Stem/Progenitor Cells, Microenvironment, Preclinical/Clinical Means to Enhance Engraftment of Cord Blood Stem Cell/Progenitor Cells, Options for the future of Regenerative Medicine, Recovery of Immune Cells in Cord Blood as well as Clinical UCB using single and double cord blood unit


News Education and CME
published 2011-11-30 07:11:05 by Nancy Hamilton


Webcasts from the recently held ESH-Eurocord- Eurocord-Ed- EBMT-Netcord World Cord Blood Congress III: Cord Blood Transplantation and Immunology of Haematopoietic Stem Cell Transplantation are now available. You will find five of the first session webcast on cord blood banking. You may either watch the webcast or view the slides in .pdf version. More webcasts will be posted shortly.

Direct link



51 articles available. Page : 1 2 3 4 5 6
51 articles available. Page : 1 2 3 4 5 6

Register Now for the FACT Cord Blood Workshop, Rome, October 2011
published 2011-10-06 11:07:50 by Nancy Hamilton

Organized in conjunction with the World Cord Blood Congress 2011. Register now for:

 

Cord Blood Inspection & Accreditation Workshop
Wednesday, October 26, 2011

Hotel Nazionale Rome
Rome
Italy

This FACT  training workshop will take place in conjuction with the World Cord Blood Congress 2011, in Rome. Register for both events by clicking on 'More Information' below.

The workshop is designed to explain the requirements for FACT-NetCord accreditation of cord blood banks. FACT representatives will be in attendance to clarify the intent of the Cord Blood Standards, provide inspectors tips for conducting inspections, and assist banks in organizing and preparing their banks for the accreditation process.

Practical application of FACT requirements stimulates discussion about effective and ineffective inspection practices and preparation techniques.

More information

New : Inauguration of the Ankara University public cord blood bank directed by Pr Meral Beksac
published 2011-09-28 13:58:47 by Benassy Arnaud

Ankara Inauguration

Allogeneic cord blood transplants are being offered to pediatric patients since 1995 in Turkey. The number of sibling-family CBTs have reached the number of twelve. The number of pediatric transplants for which the stem cell source is both cord blood and bone marrow is more: 51. Recently experience with both pediatric (n:49) and adult (n:15) unrelated cord blood transplants are amounting steadily. These number constitute approx. 3 % of all the allogeneic transplants but the trend for increase both in number and survival rates are promising. The main source of unrelated CBTs are from CBBs in Spain , NMDP, Italy and Germany. Until recently there was only autologous CB banking in Turkey limited to three private and a university CBB. In 2009 Ankara University, where the first CB storage (1994) and CBT ( 1995) was initiated was able to receive a grant that equaled to approx. 3 million euros which was spent on building a CBB with a GMP facility; renovation of the EFI accredited HLA typing laboratories, the Apheresis Unit, TRAN (Ankara University Donor Registry) and the Donor Center. The Ankara University CBB and Donor Registry are registered under BMDW for many years. Following the completion of the renovations and registration approval by the Ministry of Health, TRAN has started to recruit adult donors and cords blood donations. The grant will enable 9 000 donor (600 CB units included) costs of typing and storage. This will increase the donor and CB capacity from 4000 to 11000. On September 23 the CBB organized a opening ceremony and a scientific symposium. ESH, Eurocord and WMDA president Prof E.Gluckman and EBMT president and Anthony Nolan Director Prof A.Madrigal were the guests of honor. To an audience of 150 , the CBT experience of Turkish centers were presented which were followed by two state of art lectures by Gluckman and Madrigal. The following day a round table case discussions on best donor-CB selection was performed in the Registry site with attendees of TC coordinators. Overall the ceremony and the symposium was an important achievement in the history of transplantation in Turkey thanks to the contributions of a distinguished faculty.

Webcast of the ESH-EBMT Training Course on BLOOD AND MARROW TRANSPLANTATION
published 2011-07-04 10:19:36 by Benassy Arnaud

news_labaule Click here to access the webcast of ESH-EBMT Training Course on BLOOD AND MARROW TRANSPLANTATION, held in La Baule, France, 8-11 May 2011

How to use Eurocord-ed
published 2011-05-31 13:43:47 by Nancy Hamilton


REGISTER NOW FOR THE WORLD CORD BLOOD CONGRESS III
published 2011-05-25 15:30:23 by Benassy Arnaud

roma

CORD BLOOD TRANSPLANTATION AND IMMUNOBIOLOGY OF HAEMATOPOIETIC STEM CELL TRANSPLANT

27 - 29 October, Rome, Italy

Click here to retrieve the programme and register

About Rome, the Eternal City

 


Cord Blood Workshop
published 2011-05-25 14:50:58 by Benassy Arnaud

fact_banner

Register for the Cord Blood Workshop at the International Umbilical Cord Blood Symposium to learn how to prevent common citations! Presenters at this workshop on June 26, 2011 in San Francisco, California will address difficult requirements for cord blood banks with candid, practical information. Do you have questions or concerns about any of the following:

  • Planning, conducting, and documenting acceptable validation studies?
  • Controlling collection supplies and reagents at fixed and/or non-fixed collection sites?
  • Providing transplant centers with information regarding handling and thawing the cord blood unit, especially in accordance with the FDA guidance?
  • Knowing when to test what samples, and which tests to perform?
  • How to prepare your bank for a FACT-NetCord inspection?
  • How to become a FACT Cord Blood Inspector?

Revision of the Clinical Trials Directive 2001/20/EC Concept Paper for Public Consultation
published 2011-05-12 11:20:39 by Nancy Hamilton

The European Commission is planning to put forward, in 2012, a legislative proposal to revise the Clinical Trials Directive 2001/20/EC.
This concept paper pdf - 94 KB [94 KB] is being put out for public consultation. It presents:

  • a 'preliminary appraisal' of which option appears to be the most suitable one to address some of the key concerns of the Clinical Trials Directive, on the basis of the current state of the impact assessment; and
  • the main figures that are being used to evaluate the impacts of the different policy options.
Published May 12, 2011

Human Umbilical Cord Blood for Wound Repair
published 2011-05-10 15:10:15 by Nancy Hamilton

An article in "Wound Repair and Regeneration - The International Journal of Tissue Repair and Regeneration" authors report on  the "Promotion of cutaneous wound healing by local application of mesenchymal stem cells derived from human umbilical cord blood" to view the full article, please click  here Published May 10, 2011

European Medicines Agency releases new guidance on medicines based on SCs
published 2011-05-06 14:41:20 by Nancy Hamilton

The European Medicines Agency has released new guidance on medicines based on stem cells. The guidance covers the different types of stem cells used in medicines, and the considerations that companies need to take into account when developing medicines including stem cells or developed from stem cells.
The reflection paper on stem cell-based medicinal products (available here)  stresses the fact that companies developing medicines including stem cells need to pay close attention to the way the medicines are manufactured, to make sure that the final medicine is as consistent and reproducible as possible.
Pre-clinical and clinical testing also needs to take account of the cells' properties, ensuring that the possible risks of tumour development and rejection by the body are studied adequately and balanced against their benefits for patients.
Stem cells are naturally occurring cells in the body that have the ability to divide and produce a range of different cell types. The use of stem cells as medicines is a promising area of research as they may be able to help the body to regenerate damaged or lost tissue in diseases like Parkinson’s disease, multiple sclerosis, heart disease, liver disease, spinal cord damage or cancer.
The reflection paper was adopted by the Agency's Committee for Advanced Therapies (available here ) (CAT) on 14 January 2011. This followed a public consultation between March and June 2010 (see the overview of comments  here ) and discussion at a public workshop in May 2010 here involving 230 participants from academia, industry and regulatory authorities. Published on May 6, 2011

Testing Power of Cord Blood
published 2011-05-06 13:28:22 by Nancy Hamilton

Researchers at Monash Medical Centre in Melbourne, Australia, are  awaiting approval for a study that would use umbilical-cord blood to  treat 20 children with cerebral palsy. The researchers want to evaluate
whether cord blood can cure or alleviate symptoms of the disease. The trial is expected to commence this year. Click here to read the full article at www.theage.com.au Published May 6, 2011



51 articles available. Page : 1 2 3 4 5 6
51 articles available. Page : 1 2 3 4 5 6

WHO Transplantation of human cells, tissues and organs
published 2011-05-05 15:20:50 by Nancy Hamilton

The World Health Organisation presents their guidelines for transplantation of human cells, tissues and organs. According to the WHO "In 50 years, transplantation has become a successful worldwide practice. However, there are large differences between countries in access to suitable transplantation and in the level of safety, quality, efficacy of donation and transplantation of human cells, tissues and organs. The ethical aspects of transplantation are at the forefront. In particular, the unmet patients’ needs and the shortage of transplants lead to the temptation of trafficking in human body components for transplantation." Download the WHO's "Guiding Principles" via this link. Published May 5, 2011

Interview highlights from EBMT Annual Meeting 2011 in French and English
published 2011-05-04 09:54:11 by Nancy Hamilton

Please find slide presentations and interview summaries of the major highlights from the recent EBMT Annual Meeting held in Paris in April 2011 by clicking here.

Retrouvez la synthèse des communications majeures du Congrès EBMT 2011 sous forme de diaporamas et d'interview d'experts en suivant ce lien.

ESH-EBMT Handbook on Haemopoietic Stem Cell Transplantation
published 2011-04-22 10:22:44 by Nancy Hamilton

The ESH-EBMT Handbook (2008 edition) is available at the following Link: ESH-EBMT Handbook on Haemopoietic Stem Cell Transplantation

World Cord Blood Congress III: Cord Blood Transplantation and Immunobiology of HSCT
published 2010-11-22 10:40:43 by Benassy Arnaud

Venue: Rome, Italy
Date: 27-30 October, 2011

ESH-Eurocord-Eurocord-Ed President: E. Gluckman
Eurocord-Ed Local Local Organizers: W. Arcese, F. Locatelli, P. Rebulla
EBMT Immunobiology Working Party: A. Madrigal, A. Toubert, A. Velardi
Netcord: E. Baudoux, C. Navarrete

Registration: http://www.esh.org

WBMT - Hanoi, Vietnam
published 2010-11-22 10:38:06 by Benassy Arnaud

Venue: Hanoi, Vietnam
Date: 10-11 November 2011

Informations : www.wbmt.org
Registration : Retrieve file

FACT Workshop Agenda November 2010
published 2010-08-31 13:10:36 by Benassy Arnaud

encart_fact Click here to retrieve the Workshop Programme  for Fact Workshop, to be held in Marseille, France, November 3, 2010

World Cord Blood Congress Presentations
published 2010-04-23 10:27:01 by Benassy Arnaud

encart_marseille

Click here to read the selected presentations from WORLD CORD BLOOD CONGRESS, held in Marseille, France, 4-7 November 2010.

'Cord blood saving lives' : CNN Report
published 2010-04-14 09:57:21 by Benassy Arnaud

CNN's Dr. Sanjay Gupta reports on how blood from umbilical cords can save the lives of cancer patients.

View video published on March 2, 2010 on CNN Website

Adult somatic stem cells - new perspectives, Monaco 2009
published 2010-04-13 15:45:28 by Benassy Arnaud

monaco_encart
To view presentations from the Adult somatic stem cells - new perspectives conference held in Monaco, November 2009 click here.

(Note: you need to be a registered member to view this content. Registration is free.)

Eurocord 2009 Achievements
published 2010-04-09 13:34:52 by Administrator

Read about Eurocord's 2009 Achievements



51 articles available. Page : 1 2 3 4 5 6
51 articles available. Page : 1 2 3 4 5 6

Eurocord 2009 Achievements
published 2010-04-09 13:04:18 by Administrator

Eurocord is an international registry of cord blood transplants established in Paris, in 1995 under the direction of Dr Vanderson Rocha and Professor Eliane Gluckman. It has currently collected and validated more than 6000 cases of cord blood transplants throughout the world with approximately 70% provided by EBMT transplant centers.

EUROCORD collaborates closely with cord blood banks and EBMT centres, collecting and validating clinical data of patients transplanted with Netcord cord blood units, or receiving a cord blood transplant in an EBMT centre. This collaboration is important in order to evaluate the quality of the cord blood unit and to help cord blood banks to follow national and international system accreditation.

EUROCORD also collaborate with EBMT working parties in observational studies. In 2009, the EBMT Registry has finalized a data agreement with the EUROCORD Registry, to improve data collection in Promise. The agreement facilitates the data flow, enabling EBMT centres to submit their cord blood data once, instead of to both organizations.

In December 2009, in order to collect data of American patients receiving a European cord blood graft and vice-versa, an agreement between Eurocord-EBMT and CIBMTR was established to share clinical data outcome through the implementation of AGNIS project. AGNIS is "A Growable Network Information System", which has the goal to transmit haematopoietic stem cell transplant (HCT) data between different data bases. This project was approved and financed by the American government and it is in currently development between Eurocord and CIBMTR.

In 2009, Eurocord registry has published many articles (see below) in collaboration with EBMT working parties and National Societies. Two abstracts were accepted in the EBMT plenary session in Goteborg 2009. Prospective trials in collaboration with The French Society of HSCT (SFGM-TC) have started. Many other observational studies are on going. The main task of the Eurocord registry in 2010 is to finalize the AGNIS project and to continue and establish collaborations with cord blood banks and EBMT working parties. Many observational studies are on going and we hope to finalize most of them.

Eurocord Achievements 2009, studies and publications

  1. Plenary session of EBMT 2009
    Comparison of outcomes after intrabone versus intravenous CBT (F Frassoni)
    Reduced intensity UCBT for adults, on behalf of Eurocord and SFGM-TC (B Rio)
  2. Prospective studies in collaboration with the French society of bone Marrow transplant and cell therapy (SFGM-TC)
    RIC -UCBT for patients with AML (B Rio, PHRC): Finished recruitment
  3. Single vs Double CBT in children and young adults with acute leukemias (G Michel, PHRC, France): approved but not yet started

    Double CBT for Lymphoid malignancies (PHRC Cancer V Rocha, submission)

  4. Submitted /on going retrospective studies/proposals

Unrelated CBT for children with MDS- Leukemia, under review A Madureira/F Locatelli on behalf of Eurocord, CIBMTR and EWOG
Unrelated CBT for adults with MDS, Blood. M Robin on behalf of Eurocord and CLWP

Analysis completed and manuscripts on-going

Related CBT for children with malignant disorders AL Herr/ N Kabbara
HLA identical BM versus CB for patients with thal and SCID F Locatelli
MAC and single UCBT for adults with leukemia H Bittencourt/S Nabhan
Haplo versus CB for PID (coll. with IEWP) J Fernandes/ M Calvo
Graft failure after UCBT J Fernandes
UCBT for aplastic anemia (coll. AWP) RP de La Tour/ D Purtill
UCBT for congenital aplastic anemia (coll. AWP) R Bizetto
HLA allele-typed UBM vs UPB vs UCB in adults with AL (CIBMTR) M Eapen/V Rocha
RIC-CBT (SFGM-TC) B Rio/ V Rocha


Data collection and analysis on-going

UCBT-RIC versus UBMT-RIC for lymphoma (coll. LWP) C Arrais
HLA identical vs UBM vs UCB in Hurler's Synd. J Boelens/J Kurtzberg
KIR in other malignant and non malignant disorders( coll. IBWP) A Ruggeri/ R Willemze
NIMA and UCBT outcomes (coll. IBWP) D Purtill
UCBT for ALL in adults S Furst/ D Purtill
UCBT for ALL in children A Ruggeri/JH Dalle
Chronic GVHD and Late effects after UCBT A Crotta
Autoimmune diseases after UCBT T Daikeler
Intrabone versus IV CBT F Frassoni
Effect of HLA locus mismatch in CBT outcomes D Purtill
Unrelated CBT for hemoglobinopathies V Rocha/M Eapen/ A Ruggeri
Unrelated CBT for malignant disorders in Brazil (coll SBMTO) C Arrais

Other on-going international collaborative studies

Influence of HLA-C on engraftment (Netcord/CIBMTR-NMDP) M Eapen/V Rocha

Other proposals

Antibodies anti HLA and outcomes after UCBT P Loiseau-SFGM-TC
Relevance of cytokine/immune response gene polymorphisms in UCBT E Petersdorf
Clinical importance of MHC haplotypes in UCBT E Petersdorf
Identification of functional SNPs in UCBT E Petersdorf
Worldwide survey of UCBT (wBMT) Eurocord/NYBC/CIBMTR/Asian-Pacific Registry
Bank effect on outcomes: Netcord banks H Bittencourt/V Rocha
Infections M Robin, JP Yves, F Legrand/I Ionescu


4. Publications: 2009

  1. Rocha V, Broxymeyer H. New approaches for improving engraftment after Cord Blood Transplantation.Biol Blood Marrow Transplant. 2009 Nov 4. [Epub ahead of print]
  2. Rocha V, Kabbara N, Ionescu I, Ruggeri A, Purtill D, Gluckman E. Pediatric related and unrelated cord blood transplantation for malignant diseases.Bone Marrow Transplant. 2009 Nov;44(10):653-9. Epub 2009 Oct 5.
  3. Rocha V, Gluckman E; Eurocord-Netcord registry and European Blood and Marrow Transplant group. Improving outcomes of cord blood transplantation: HLA matching, cell dose and other graft- and transplantation-related factors.Br J Haematol. 2009 Oct;147(2):262-74.
  4. Barker JN, Rocha V, Scaradavou A. Optimizing unrelated donor cord blood transplantation.Biol Blood Marrow Transplant. 2009;15 (1 Suppl):154-61.
  5. Willemze R, Rodrigues CA, Labopin M, Sanz G, Michel G, Socié G, Rio B, Sirvent A, Renaud M, Madero L, Mohty M, Ferra C, Garnier F, Loiseau P, Garcia J, Lecchi L, Kögler G, Beguin Y, Navarrete C, Devos T, Ionescu I, Boudjedir K, Herr AL, Gluckman E, Rocha V. KIR-ligand incompatibility in the graft-versus-host direction improves outcomes after umbilical cord blood transplantation for acute leukemia. Leukemia. 2009 , 23:492-500.
  6. Rodrigues CA, Sanz G, Brunstein CG, Sanz J, Wagner JE, Renaud M, de Lima M, Cairo MS, Fürst S, Rio B, Dalley C, Carreras E, Harousseau JL, Mohty M, Taveira D, Dreger P, Sureda A, Gluckman E, Rocha V.Analysis of risk factors for outcomes after unrelated cord blood transplantation in adults with lymphoid malignancies: a study by the Eurocord-Netcord and lymphoma working party of the European group for blood and marrow transplantation. J Clin Oncol. 2009 ;27:256-63.
  7. Boelens JJ, Rocha V, Aldenhoven M, Wynn R, O'Meara A, Michel G, Ionescu I, Parikh S, Prasad VK, Szabolcs P, Escolar M, Gluckman E, Cavazzana-Calvo M, Kurtzberg J; EUROCORD, Inborn error Working Party of EBMT and Duke University. Risk factor analysis of outcomes after unrelated cord blood transplantation in patients with hurler syndrome. Biol Blood Marrow Transplant. 2009;15:618-25.
  8. Gluckman E, Rocha V. Cord blood transplantation: state of the art. Haematologica. 2009 ;94:451-4.
  9. Rocha V, Mohty M, Gluckman E, Rio B; Eurocord; Reduced-Intensity Conditioning Subcommittee of the Acute Leukaemia Working Party; French Society of Bone Marrow Transplantation and Cellular Therapy. Reduced-intensity conditioning regimens before unrelated cord blood transplantation in adults with acute leukaemia and other haematological malignancies. Curr Opin Oncol. 2009 Jun;21 Suppl 1:S31-4.

 

 


36th Annual Meeting of the European Group for Blood and Marrow Transplantation
published 2010-04-09 10:47:55 by Benassy Arnaud

encart

Donate your Cord Blood
published 2010-02-23 11:00:25 by Administrator

Italian Brochure on UCB Donation

Free webinar: Cord Blood Potency, Quality and Release: Assays Compliant with FDA Regulations
published 2010-02-16 16:59:02 by Administrator

Click to enlarge

cord_blood_potency_smallUmbilical cord blood is now considered a drug by the FDA.

The new Guidance for Industry: Minimally Manipulated, Unrelated Allogeneic Placental/Umbilical Cord Blood Intended for Hematopoietic Reconstitution for Specific Indications requires cord blood banks to measure identity, potency (strength) and quality of cord blood prior to its intended use. The parameters recommended by FDA/CBER are often at odds with, and in many cases, apparently contradictory to, the regulations. The Guidance allows for an "alternative approach" and other comparable and equivalent assays to be performed, providing the assays have been validated.

This webinar discusses the recommended assays in the Guidance and alternative, validated assays that have been designed specifically for the intended purpose.

Register (this will bring you to a site outside of Eurocord-ed.org):

Wed, Feb 17, 2010 9:00 AM - 10:00 AM MST (5pm GMT)

Wed, Mar 3, 2010 9:00 AM - 10:00 AM MST(5pm GMT)

 

Notch-mediated expansion of human cord blood progenitor cells capable of rapid myeloid reconstitution
published 2010-02-08 17:09:58 by Administrator

Authors: Colleen Delaney, Shelly Heimfeld, Carolyn Brashem-Stein, Howard Voorhies, Ronald L Manger & Irwin D Bernstein

Read article in Nature.

 

'I wanted my baby's cord blood to save'
published 2010-02-04 15:37:54 by Administrator

BBC News

January 18, 2010

When Natalie Salama-Levy gives birth to her second child at the end of next month she wanted to be able to donate its cord blood. But despite the fact that she is prepared to donate to help others, she cannot.

View article on BBC News website

NetCord-FACT International Standards for Cord Blood Collection, Banking, and Release for Administration
published 2009-12-29 11:26:31 by Administrator

SIGNIFICANT CHANGES FROM THIRD EDITION TO FOURTH EDITION

View document pdf_button

ESBB Annual Meeting, Marseille, 16-19 November 2011
published 2009-12-18 09:57:47 by Administrator

Conference theme: "Identifying the challenges and the opportunities for biorepositories today and in the next five years".

Confirmed speakers include: Christian Bréchot, Ann Cambon-Thomsen, Fay Betsou, Uwe Oelmuller, Kurt Zatloukal, Ole Seburg, Jim Vaught and Georges Dagher.

Registration, exhibitor and sponsor information now available: http://www.esbb.org/meetings.html

EUROCORD-ED and TRANSMED: Transfusion Medicine, Cellular and Tissue Therapies link up to share online resources
published 2009-10-16 13:52:08 by Administrator

transmed

TRANSMED is a curriculum development project funded by the Lifelong Learning Program of the European Commission. Its goal is to design a European master program in Transfusion Medicine. EUROCORD-ED and TRANSMED projects share many key partners including the University of Liège (Belgium), the European School of Haematology (France), the Foundation Ospedale Maggiore Policlinico-Mangiagalli e Regina Elena (Italy), and the Blood and Tissue Bank of Catalonia (Spain). To learn more about TRANSMED, please visit www.transmederasmus.eu

Cord Blood Saved My Life
published 2009-08-24 16:55:19 by Administrator

A website from one of the first patients transplanted for Fanconi Anemia with UCB from a HLA identical sister

www.nataliecurry.com



51 articles available. Page : 1 2 3 4 5 6
51 articles available. Page : 1 2 3 4 5 6

A European Model for Life Long Learning in Bio-Medical Science
published 2009-05-22 08:42:24 by Administrator

Read the article here pdf_button

Profile of the Mandelieu Cord Blood Conference October 2008
published 2009-04-30 14:37:46 by Administrator

Read a profile of the Mandelieu Cord Blood Conference October 2008 pdf_button

EUROCORD-ED in the news
published 2009-04-28 10:14:44 by Administrator

Head of Haematology at Eurocord Dr Eliane Gluckman describes the development of a network to support and promote the use of cord blood, and the training required in technology and transplantation.

Published in the UK Public Service Review, Issue 17.

The Eurocet Project
published 2009-04-17 10:20:15 by Administrator

Article 10, paragraph 2 of the European Directive 2004/23/EC requires the Competent Authority to establish and maintain a publicly accessible register of tissue establishments specifying the activities for which they have been authorised. In addition, paragraph 3 states "Member States and the Commission shall establish a network linking the national tissue establishment registers".

The Eurocet Project, which was funded by the European Commission, has established The Eurocet Registry which will include the name and address of the Tissue Establishment, and the type of tissue and / or cell to which the authorisation pertains. More information on the Eurocet Registry can be found at: www.eurocet.org.

Copenhagen Quality Assurance in VET
published 2009-03-09 10:41:47 by Administrator

Fundamentals of a Common Quality Assurance Framework (CQAF) for Vocational Educational Training in Europe

View document pdf_button

Eurocord-Ed Photos From 20th Anniversary Celebrations
published 2009-03-06 19:15:48 by Administrator

Click here to see photographs from the Mandelieu conference

Published March 6, 2009

Focus on Banking
published 2009-03-06 18:53:33 by Administrator

The Ospedale Maggiore hospital in Milan was originally founded in 1456. The "Policlinico" (General Hospital), Mangiagalli and Regina Elena Ospedale Maggiore Foundation was officially opened in 2005. The mission of exploiting the potentials of cellular therapy and of performing biobanking research was given to a unit named the Center of Transfusion Medicine, Cellular Therapy and Cryobiology (CTMC).

Currently, the CTMC includes five sections: one of which includes the Milano Cord Blood Bank, with an inventory of 6627 allogeneic cord blood units, 350 of which have been transplanted in 21 countries (39 units in 2007). Published March 6, 2009

Latimer '09 Webcasts
published 2009-03-06 18:49:36 by Administrator

webcast_latimer uk_may09To view 8 presentations from The 13th ESH-EBMT Training Course on Blood and Marrow Transplantation held in Latimer, UK, May 25-28, 2009 click here.

(Note: you need to be a registered member to view this content)

Pescara '09 Webcasts
published 2009-03-06 18:49:36 by Administrator

webcast_pescara_nov09_2To view presentations from the Organisational, Technical and Clinical aspects of Cord Blood Banking conference held in Pescara, Italy, November 11-15 2009 click here.

(Note: you need to be a registered member to view this content. Registration is free.)

Advanced Therapy Medicinal Products (ATMP) Regulations 1394/2007/EC 20th February, 2009
published 2009-03-06 18:31:46 by Administrator

An ATMP is a medicinal product as defined in Directive 2001/83/EC and is either:

  • a gene therapy medicinal product as defined in Part IV of Annex I to Directive 2001/83/EC;
  • a somatic cell therapy medicinal product as defined in Part IV of Annex I to Directive 2001/83/EC; or
  • a tissue engineered product as defined in Article 2 1 (b) of the ATMP Regulation (1394/2007/EC).

All final and draft guidelines are published on the EMEA Advanced Therapies webpage To view the ATMP regulation 1394/2007/EC click here pdf_button



51 articles available. Page : 1 2 3 4 5 6
51 articles available. Page : 1 2 3 4 5 6

New publication on the History of Cord Blood Transplantation by Eliane Gluckman
published 2009-03-06 18:04:35 by Administrator

Since the first human cord blood transplant, performed twenty years ago, cord blood banks have been established worldwide for collection and cryopreservation of cord blood for allogeneic hematopoietic stem cell transplant. A global network of cord blood banks and transplant centers has been established for a common inventory and study of clinical outcomes.

Read full article



51 articles available. Page : 1 2 3 4 5 6